PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-Mar-2021 ADDING MULTIMEDIA Chimeron Bio Appoints Dr. Juan José Daboub, Eminent Expert in International Trade and Business Development and Dr. Wilmot James, Distinguished Global Health Policy Scholar to its Accessible Medicines Advisory Board (AMAB) Businesswire
10-Mar-2021 Takeda adquire a Maverick Therapeutics para avançar as terapias de engajamento de células T para tumores sólidos e expandir o novo portfólio de imuno-oncologia Businesswire
10-Mar-2021 Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST) Businesswire
10-Mar-2021 Lynne Ensor, Parexel Chair of SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference, exclusive interview released SMi Group
10-Mar-2021 Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon Businesswire
10-Mar-2021 Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes Businesswire
10-Mar-2021 Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon Businesswire
10-Mar-2021 Transgene: Significant Milestones Achieved on All Drug Candidates in 2020 and Financial Visibility until 2022 Businesswire
10-Mar-2021 Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers Businesswire
10-Mar-2021 AbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19 Businesswire
10-Mar-2021 武田將收購Maverick Therapeutics,以推進T細胞接合治療實體瘤,擴大新型免疫腫瘤產品組合 Businesswire
10-Mar-2021 Chimeron Bio Appoints Dr. Juan José Daboub, Eminent Expert in International Trade and Business Development and Dr. Wilmot James, Distinguished Global Health Policy Scholar to its Accessible Medicines Advisory Board (AMAB) Businesswire
10-Mar-2021 武田将收购Maverick Therapeutics,以推进T细胞接合治疗实体瘤,扩大新型免疫肿瘤产品组合 Businesswire
10-Mar-2021 Venatorx Pharmaceuticals Expands Anti-Infective Portfolio with HBV Candidate Businesswire
10-Mar-2021 Drug Topics® Introduces Complementary Independent Pharmacy Resource Total Pharmacy® Businesswire
10-Mar-2021 RGN-259: A TB4-based Sterile and Preservative-free Eye Drop, As a Novel Treatment for Dry Eye and Neurotrophic Keratitis (NK) - Global Emerging Insight and Market Forecast 2021-2030 - ResearchAndMarkets.com Businesswire
10-Mar-2021 Cybin to Present at the Stifel GMP Healthcare Conference – Healthcare Psychedelics: Addressing the Global Mental Health Crisis Businesswire
10-Mar-2021 Ignyte Acquisition Corp. Announces Separate Trading of its Common Stock and Warrants Businesswire
10-Mar-2021 Outcome Capital Expands Life Science Practice with Addition of Digital Health Industry Veterans Businesswire
10-Mar-2021  ImmunityBio Begins Trading Today on Nasdaq as Large Cap Biotechnology Company Businesswire